{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:55:34Z","timestamp":1782255334996,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Adenoid cystic cancer arising in the salivary glands has distinctive features such as perineural invasion, distant metastasis, and a variable prognosis. In salivary gland cancer, c-kit, EGFR, and VEGF are representative molecular markers that may predict remnant and recurrent tumors. In this study, the expression of c-kit, EGFR, and VEGF in adenoid cystic cancer was evaluated, and the relationships between the expression of these markers and the clinical findings were investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The medical records of 48 patients who were treated for parotid adenoid cystic cancer from January 1990 to January 2006 were reviewed. The tumor location, size, histological subtypes, perineural invasion, the resected margin status, and lymph node metastasis were assessed. Immunohistochemical staining and semiquantitative analysis of c-kit, EGFR and VEGF were performed. The relationship between the expression of each marker and the clinicopathological factors were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Positive c-kit immunostaining was present in 45 patients (94%), with weak positivity (+1) in 23, moderate positivity (+2) in 19 and strong positivity (+3) in three. Positive EGFR immunostaining was observed in 27 (56%), with weak positivity (+1) in 19 and moderate positivity (+2) in eight with no strong positive staining. Positive VEGF immunostaining was present in 42 patients (88%) with weak positivity (+1) in 12, moderate positivity (+2) in 17, and strong positivity (+3) in 13. Only the expression of VEGF was significantly higher in parotid gland tumors than in any other gland (<jats:italic>P<\/jats:italic> = 0.032). Marginal involvement was associated with strong VEGF expression (<jats:italic>P<\/jats:italic> = 0.02). No marker was significantly correlated with recurrence or the survival rate. Lymph node status was related to the survival rate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The expression of c-kit, EGRF, and VEGF had no predictive value for recurrence or the prognosis of adenoid cystic cancer. Only the lymph node status was related to the prognosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-7819-10-266","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T23:14:16Z","timestamp":1355267656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Prognostic value of expression of molecular markers in adenoid cystic cancer of the salivary glands compared with lymph node metastasis: a retrospective study"],"prefix":"10.1186","volume":"10","author":[{"given":"Seok Ki","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Su","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Se","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Yoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Ja","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Yuhl","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,11]]},"reference":[{"key":"1201_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ijrobp.2006.04.014","volume":"66","author":"AM Chen","year":"2006","unstructured":"Chen AM, Bucci MK, Weinberg V, Garcia J, Quivey JM, Schechter NR, Phillips TL, Fu KK, Eisele DW: Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys. 2006, 66: 152-159. 10.1016\/j.ijrobp.2006.04.014.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1201_CR2","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/0360-3016(95)00122-F","volume":"32","author":"AS Garden","year":"1995","unstructured":"Garden AS, Weber RS, Morrison WH, Ang KK, Peters LJ: The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys. 1995, 32: 619-626. 10.1016\/0360-3016(95)00122-F.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1201_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/hed.10380","volume":"26","author":"WM Mendenhall","year":"2004","unstructured":"Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Hinerman RW, Villaret DB: Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck. 2004, 26: 154-162. 10.1002\/hed.10380.","journal-title":"Head Neck"},{"key":"1201_CR4","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.oraloncology.2006.01.001","volume":"42","author":"RL Dodd","year":"2006","unstructured":"Dodd RL, Slevin NJ: Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol. 2006, 42: 759-769. 10.1016\/j.oraloncology.2006.01.001.","journal-title":"Oral Oncol"},{"key":"1201_CR5","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00432-008-0377-3","volume":"134","author":"AD Elkin","year":"2008","unstructured":"Elkin AD, Jacobs CD: Tamoxifen for salivary gland adenoid cystic carcinoma: report of two cases. J Cancer Res Clin Oncol. 2008, 134: 1151-1153. 10.1007\/s00432-008-0377-3.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1201_CR6","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/j.1349-7006.2008.00826.x","volume":"99","author":"JF He","year":"2008","unstructured":"He JF, Ge MH, Zhu X, Chen C, Tan Z, Li YN, Gu ZY: Expression of RUNX3 in salivary adenoid cystic carcinoma: implications for tumor progression and prognosis. Cancer Sci. 2008, 99: 1334-1340. 10.1111\/j.1349-7006.2008.00826.x.","journal-title":"Cancer Sci"},{"key":"1201_CR7","doi-asserted-by":"publisher","first-page":"7334","DOI":"10.1158\/1078-0432.CCR-05-0241","volume":"11","author":"J Zhang","year":"2005","unstructured":"Zhang J, Peng B, Chen X: Expressions of nuclear factor kappaB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. Clin Cancer Res. 2005, 11: 7334-7343. 10.1158\/1078-0432.CCR-05-0241.","journal-title":"Clin Cancer Res"},{"key":"1201_CR8","first-page":"176","volume":"4","author":"RS DiPaola","year":"1997","unstructured":"DiPaola RS, Kuczynski WI, Onodera K, Ratajczak MZ, Hijiya N, Moore J, Gewirtz AM: Evidence for a functional kit receptor in melanoma, breast, and lung carcinoma cells. Cancer gene therapy. 1997, 4: 176-182.","journal-title":"Cancer gene therapy"},{"key":"1201_CR9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1126\/science.279.5350.577","volume":"279","author":"S Hirota","year":"1998","unstructured":"Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998, 279: 577-580. 10.1126\/science.279.5350.577.","journal-title":"Science"},{"key":"1201_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0304-3835(00)00387-6","volume":"154","author":"YM Jeng","year":"2000","unstructured":"Jeng YM, Lin CY, Hsu HC: Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma. Cancer Lett. 2000, 154: 107-111. 10.1016\/S0304-3835(00)00387-6.","journal-title":"Cancer Lett"},{"key":"1201_CR11","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.oraloncology.2009.05.635","volume":"45","author":"LD Locati","year":"2009","unstructured":"Locati LD, Perrone F, Losa M, Mela M, Casieri P, Orsenigo M, Cortelazzi B, Negri T, Tamborini E, Quattrone P, Bossi P, Rinaldi G, Bergamini C, Calderone RG, Liberatoscioli C, Licitra L: Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs). Oral Oncol. 2009, 45: 986-990. 10.1016\/j.oraloncology.2009.05.635.","journal-title":"Oral Oncol"},{"key":"1201_CR12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1200\/JCO.2005.06.125","volume":"23","author":"SJ Hotte","year":"2005","unstructured":"Hotte SJ, Winquist EW, Lamont E, MacKenzie M, Vokes E, Chen EX, Brown S, Pond GR, Murgo A, Siu LL: Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study. J Clin Oncol. 2005, 23: 585-590.","journal-title":"J Clin Oncol"},{"key":"1201_CR13","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1200\/JCO.1993.11.10.1873","volume":"11","author":"O Dassonville","year":"1993","unstructured":"Dassonville O, Formento JL, Francoual M, Ramaioli A, Santini J, Schneider M, Demard F, Milano G: Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol. 1993, 11: 1873-1878.","journal-title":"J Clin Oncol"},{"key":"1201_CR14","first-page":"885","volume":"8","author":"AK Gupta","year":"2002","unstructured":"Gupta AK, McKenna WG, Weber CN, Feldman MD, Goldsmith JD, Mick R, Machtay M, Rosenthal DI, Bakanauskas VJ, Cerniglia GJ, Bernhard EJ, Weber RS, Muschel RJ: Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. Clin Cancer Res. 2002, 8: 885-892.","journal-title":"Clin Cancer Res"},{"key":"1201_CR15","first-page":"4164","volume":"5","author":"W Xia","year":"1999","unstructured":"Xia W, Lau YK, Zhang HZ, Xiao FY, Johnston DA, Liu AR, Li L, Katz RL, Hung MC: Combination of EGFR, HER-2\/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res. 1999, 5: 4164-4174.","journal-title":"Clin Cancer Res"},{"key":"1201_CR16","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1600-0714.2006.00421.x","volume":"35","author":"KB Sorensen","year":"2006","unstructured":"Sorensen KB, Godballe C, de Stricker K, Krogdahl A: Parotid carcinoma: expression of kit protein and epidermal growth factor receptor. J Oral Pathol Med. 2006, 35: 286-291. 10.1111\/j.1600-0714.2006.00421.x.","journal-title":"J Oral Pathol Med"},{"key":"1201_CR17","first-page":"1029","volume":"146","author":"HF Dvorak","year":"1995","unstructured":"Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor\/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995, 146: 1029-1039.","journal-title":"Am J Pathol"},{"key":"1201_CR18","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1034\/j.1600-0714.2003.00073.x-i1","volume":"32","author":"JJ Lim","year":"2003","unstructured":"Lim JJ, Kang S, Lee MR, Pai HK, Yoon HJ, Lee JI, Hong SP, Lim CY: Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis. J Oral Pathol Med. 2003, 32: 552-561.","journal-title":"J Oral Pathol Med"},{"key":"1201_CR19","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1158\/1535-7163.MCT-05-0228","volume":"5","author":"MN Younes","year":"2006","unstructured":"Younes MN, Park YW, Yazici YD, Gu M, Santillan AA, Nong X, Kim S, Jasser SA, El-Naggar AK, Myers JN: Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model. Mol Cancer Ther. 2006, 5: 2696-2705. 10.1158\/1535-7163.MCT-05-0228.","journal-title":"Mol Cancer Ther"},{"key":"1201_CR20","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.oraloncology.2006.12.012","volume":"43","author":"A Milano","year":"2007","unstructured":"Milano A, Longo F, Basile M, Iaffaioli RV, Caponigro F: Recent advances in the treatment of salivary gland cancers: emphasis on molecular targeted therapy. Oral Oncol. 2007, 43: 729-734. 10.1016\/j.oraloncology.2006.12.012.","journal-title":"Oral Oncol"},{"key":"1201_CR21","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1365-2559.2008.03159.x","volume":"53","author":"T Ettl","year":"2008","unstructured":"Ettl T, Schwarz S, Kleinsasser N, Hartmann A, Reichert TE, Driemel O: Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas. Histopathology. 2008, 53: 567-577. 10.1111\/j.1365-2559.2008.03159.x.","journal-title":"Histopathology"},{"key":"1201_CR22","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1288\/00005537-199511000-00003","volume":"105","author":"RN Beckhardt","year":"1995","unstructured":"Beckhardt RN, Weber RS, Zane R, Garden AS, Wolf P, Carrillo R, Luna MA: Minor salivary gland tumors of the palate: clinical and pathologic correlates of outcome. Laryngoscope. 1995, 105: 1155-1160. 10.1288\/00005537-199511000-00003.","journal-title":"Laryngoscope"},{"key":"1201_CR23","first-page":"671","volume":"12","author":"RH Spiro","year":"1998","unstructured":"Spiro RH: Management of malignant tumors of the salivary glands. Oncology (Williston Park). 1998, 12: 671-680. discussion 683","journal-title":"Oncology (Williston Park)"},{"key":"1201_CR24","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1200\/JCO.2007.13.4452","volume":"26","author":"CD Blanke","year":"2008","unstructured":"Blanke CD, Rankin C, Demetri GD, Ryan CW, von Mehren M, Benjamin RS, Raymond AK, Bramwell VH, Baker LH, Maki RG, Tanaka M, Hecht JR, Heinrich MC, Fletcher CD, Crowley JJ, Borden EC: Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. J Clin Oncol. 2008, 26: 626-632. 10.1200\/JCO.2007.13.4452.","journal-title":"J Clin Oncol"},{"key":"1201_CR25","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/hed.20094","volume":"26","author":"JC Alcedo","year":"2004","unstructured":"Alcedo JC, Fabrega JM, Arosemena JR, Urrutia A: Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: report of two successfully treated cases. Head Neck. 2004, 26: 829-831. 10.1002\/hed.20094.","journal-title":"Head Neck"},{"key":"1201_CR26","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.oraloncology.2005.05.005","volume":"41","author":"K Freier","year":"2005","unstructured":"Freier K, Flechtenmacher C, Walch A, Devens F, Muhling J, Lichter P, Joos S, Hofele C: Differential KIT expression in histological subtypes of adenoid cystic carcinoma (ACC) of the salivary gland. Oral Oncol. 2005, 41: 934-939. 10.1016\/j.oraloncology.2005.05.005.","journal-title":"Oral Oncol"},{"key":"1201_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF00492581","volume":"87","author":"K Tsukitani","year":"1987","unstructured":"Tsukitani K, Tatemoto Y, Noda Y, Mori M, Hayashi T, Kato K: Immunohistochemical detection of human epidermal growth factor in submandibular glands and their tumors using a polyclonal antiserum and a monoclonal antibody. Histochemistry. 1987, 87: 293-300. 10.1007\/BF00492581.","journal-title":"Histochemistry"},{"key":"1201_CR28","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.joms.2005.12.074","volume":"65","author":"G Warburton","year":"2007","unstructured":"Warburton G, Nikitakis NG, Roberson P, Marinos NJ, Wu T, Sauk JJ: Jr, Ord RA, Wahl SM: Histopathological and lymphangiogenic parameters in relation to lymph node metastasis in early stage oral squamous cell carcinoma. J Oral Maxillofac Surg. 2007, 65: 475-484. 10.1016\/j.joms.2005.12.074.","journal-title":"J Oral Maxillofac Surg"},{"key":"1201_CR29","first-page":"455","volume":"38","author":"H Zhang","year":"2003","unstructured":"Zhang H, Su SW, Zheng Y, Wang L, Ma XD: Expression of nuclear factor-kappa B mRNA, inducible nitric oxide synthase and interleukin-6 in nasal polyp and its role. Zhonghua Er Bi Yan Hou Ke Za Zhi. 2003, 38: 455-458.","journal-title":"Zhonghua Er Bi Yan Hou Ke Za Zhi"},{"key":"1201_CR30","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.1200\/JCO.2005.04.192","volume":"23","author":"HS Rugo","year":"2005","unstructured":"Rugo HS, Herbst RS, Liu G, Park JW, Kies MS, Steinfeldt HM, Pithavala YK, Reich SD, Freddo JL, Wilding G: Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical results. J Clin Oncol. 2005, 23: 5474-5483. 10.1200\/JCO.2005.04.192.","journal-title":"J Clin Oncol"},{"key":"1201_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1054\/ijom.2003.0448","volume":"33","author":"H Kokemueller","year":"2004","unstructured":"Kokemueller H, Eckardt A, Brachvogel P, Hausamen JE: Adenoid cystic carcinoma of the head and neck-a 20 years experience. Int J Oral Maxillofac Surg. 2004, 33: 25-31. 10.1054\/ijom.2003.0448.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"1201_CR32","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.oraloncology.2008.01.004","volume":"44","author":"JP Agarwal","year":"2008","unstructured":"Agarwal JP, Jain S, Gupta T, Tiwari M, Laskar SG, Dinshaw KA, Chaturvedi P, D\u2019Cruz AK, Shrivastava SK: Intraoral adenoid cystic carcinoma: prognostic factors and outcome. Oral Oncol. 2008, 44: 986-993. 10.1016\/j.oraloncology.2008.01.004.","journal-title":"Oral Oncol"},{"key":"1201_CR33","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.oraloncology.2004.12.004","volume":"41","author":"AD Rapidis","year":"2005","unstructured":"Rapidis AD, Givalos N, Gakiopoulou H, Faratzis G, Stavrianos SD, Vilos GA, Douzinas EE, Patsouris E: Adenoid cystic carcinoma of the head and neck. Clinicopathological analysis of 23 patients and review of the literature. Oral Oncol. 2005, 41: 328-335. 10.1016\/j.oraloncology.2004.12.004.","journal-title":"Oral Oncol"},{"key":"1201_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0167-8140(99)00084-5","volume":"52","author":"QT Le","year":"1999","unstructured":"Le QT, Birdwell S, Terris DJ, Gabalski EC, Varghese A, Fee W, Goffinet DR: Postoperative irradiation of minor salivary gland malignancies of the head and neck. Radiother Oncol. 1999, 52: 165-171. 10.1016\/S0167-8140(99)00084-5.","journal-title":"Radiother Oncol"},{"key":"1201_CR35","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0002-9610(05)80721-4","volume":"164","author":"RH Spiro","year":"1992","unstructured":"Spiro RH, Huvos AG: Stage means more than grade in adenoid cystic carcinoma. Am J Surg. 1992, 164: 623-628. 10.1016\/S0002-9610(05)80721-4.","journal-title":"Am J Surg"},{"key":"1201_CR36","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.oraloncology.2011.12.005","volume":"48","author":"Q Li","year":"2012","unstructured":"Li Q, Zhang XR, Liu XK, Liu ZM, Liu WW, Li H, Guo ZM: Long-term treatment outcome of minor salivary gland carcinoma of the hard palate. Oral Oncol. 2012, 48: 456-62. 10.1016\/j.oraloncology.2011.12.005.","journal-title":"Oral Oncol"},{"key":"1201_CR37","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0002-9610(97)00153-0","volume":"174","author":"RH Spiro","year":"1997","unstructured":"Spiro RH: Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg. 1997, 174: 495-498. 10.1016\/S0002-9610(97)00153-0.","journal-title":"Am J Surg"},{"key":"1201_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000658-190707000-00001","volume":"46","author":"WS Halsted","year":"1907","unstructured":"Halsted WS: The results of radical operations for the cure of carcinoma of the breast. Ann Surg. 1907, 46: 1-19. 10.1097\/00000658-190707000-00001.","journal-title":"Ann Surg"},{"key":"1201_CR39","doi-asserted-by":"publisher","first-page":"10007","DOI":"10.1158\/0008-5472.CAN-08-0186","volume":"68","author":"B Fisher","year":"2008","unstructured":"Fisher B: Biological research in the evolution of cancer surgery: a personal perspective. Cancer Res. 2008, 68: 10007-10020. 10.1158\/0008-5472.CAN-08-0186.","journal-title":"Cancer Res"},{"key":"1201_CR40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrclinonc.2011.44","volume":"8","author":"RR Weichselbaum","year":"2011","unstructured":"Weichselbaum RR, Hellman S: Oligometastases revisited. Nature Rev Clin Oncol. 2011, 8: 378-382.","journal-title":"Nature Rev Clin Oncol"},{"key":"1201_CR41","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/MLG.0b013e31816a7120","volume":"118","author":"A Ballonoff","year":"2008","unstructured":"Ballonoff A, Raben D, Rusthoven KE, Bassetti M, Kane M, Song JI, Chen C: Outcomes of patients with n3 neck nodes treated with chemoradiation. Laryngoscope. 2008, 118: 995-998. 10.1097\/MLG.0b013e31816a7120.","journal-title":"Laryngoscope"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-10-266.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:57:49Z","timestamp":1630533469000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/1477-7819-10-266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1201"],"URL":"https:\/\/doi.org\/10.1186\/1477-7819-10-266","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"26 June 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"266"}}